全文获取类型
收费全文 | 90905篇 |
免费 | 6066篇 |
国内免费 | 13篇 |
出版年
2023年 | 578篇 |
2022年 | 729篇 |
2021年 | 1535篇 |
2020年 | 1254篇 |
2019年 | 1333篇 |
2018年 | 2886篇 |
2017年 | 2625篇 |
2016年 | 3260篇 |
2015年 | 4301篇 |
2014年 | 4462篇 |
2013年 | 5769篇 |
2012年 | 6959篇 |
2011年 | 6357篇 |
2010年 | 4034篇 |
2009年 | 3386篇 |
2008年 | 4988篇 |
2007年 | 4729篇 |
2006年 | 4540篇 |
2005年 | 3918篇 |
2004年 | 3827篇 |
2003年 | 3420篇 |
2002年 | 3203篇 |
2001年 | 1933篇 |
2000年 | 1810篇 |
1999年 | 1511篇 |
1998年 | 801篇 |
1997年 | 600篇 |
1996年 | 600篇 |
1995年 | 566篇 |
1994年 | 451篇 |
1993年 | 397篇 |
1992年 | 758篇 |
1991年 | 691篇 |
1990年 | 607篇 |
1989年 | 589篇 |
1988年 | 565篇 |
1987年 | 491篇 |
1986年 | 470篇 |
1985年 | 501篇 |
1984年 | 466篇 |
1983年 | 325篇 |
1982年 | 299篇 |
1981年 | 252篇 |
1980年 | 268篇 |
1979年 | 319篇 |
1978年 | 296篇 |
1975年 | 273篇 |
1974年 | 278篇 |
1973年 | 286篇 |
1972年 | 233篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
101.
Transthyretin (TTR) protects against A-Beta toxicity by binding the peptide thus inhibiting its aggregation. Previous work showed different TTR mutations interact differently with A-Beta, with increasing affinities correlating with decreasing amyloidogenecity of the TTR mutant; this did not impact on the levels of inhibition of A-Beta aggregation, as assessed by transmission electron microscopy. Our work aimed at probing differences in binding to A-Beta by WT, T119M and L55P TTR using quantitative assays, and at identifying factors affecting this interaction. We addressed the impact of such factors in TTR ability to degrade A-Beta. Using a dot blot approach with the anti-oligomeric antibody A11, we showed that A-Beta formed oligomers transiently, indicating aggregation and fibril formation, whereas in the presence of WT and T119M TTR the oligomers persisted longer, indicative that these variants avoided further aggregation into fibrils. In contrast, L55PTTR was not able to inhibit oligomerization or to prevent evolution to aggregates and fibrils. Furthermore, apoptosis assessment showed WT and T119M TTR were able to protect against A-Beta toxicity. Because the amyloidogenic potential of TTR is inversely correlated with its stability, the use of drugs able to stabilize TTR tetrameric fold could result in increased TTR/A-Beta binding. Here we showed that iododiflunisal, 3-dinitrophenol, resveratrol, [2-(3,5-dichlorophenyl)amino] (DCPA) and [4-(3,5-difluorophenyl)] (DFPB) were able to increase TTR binding to A-Beta; however only DCPA and DFPB improved TTR proteolytic activity. Thyroxine, a TTR ligand, did not influence TTR/A-Beta interaction and A-Beta degradation by TTR, whereas RBP, another TTR ligand, not only obstructed the interaction but also inhibited TTR proteolytic activity. Our results showed differences between WT and T119M TTR, and L55PTTR mutant regarding their interaction with A-Beta and prompt the stability of TTR as a key factor in this interaction, which may be relevant in AD pathogenesis and for the design of therapeutic TTR-based therapies. 相似文献
102.
Ohne Zusammenfassung 相似文献
103.
104.
Fátima H. Vaz Patrícia M. Machado Rita D. Brand?o Cátia T. Laranjeira Joana S. Eugénio Aires H. Fernandes Saudade P. André 《The journal of histochemistry and cytochemistry》2007,55(11):1105-1113
Only 20-25% of families screened for BRCA1/2 mutations are found positive. Because only a positive result is informative, we studied the role of BRCA1/2 immunohistochemistry as an additional method for patient selection. From 53 high-risk-affected probands, 18 (34%) had available paraffin blocks of their tumors and were selected for this study. Mutation screening was done by conformation-sensitive gel electrophoresis and multiplex ligation-dependent probe amplification. For immunohistochemistry, 21 neoplastic specimens (15 breast carcinomas, 5 ovary neoplasms, and 1 rectal adenocarcinoma) were analyzed with BRCA1 (monoclonal antibody, Ab-1, oncogene) and BRCA2 (polyclonal antibody, Ab-2, oncogene) antibodies. Absence of the BRCA1 protein was confirmed in negative tumors by Western blotting. Seven patients were positive for BRCA1/2 mutations: 5 for BRCA1 and 2 for BRCA2. Four out of five positive patients had tumors negative for BRCA1 immunostaining, and the remaining 13 BRCA1-negative patients had positive BRCA1 immunostaining in all tumor samples. Sensitivity to predict for BRCA1 mutation carriers was 80%, and specificity was 100%, with a positive predictive value of 100% and a negative predictive value of 93%. This correlation was statistically significant (p=0.001). No correlation was observed for BRCA2. If larger studies confirm these results, high-risk patients with BRCA1-negative tumors should be screened first for this gene. 相似文献
105.
106.
I Martínez de Mara?ón N Chaudanson N Joly P Gervais 《Biotechnology and bioengineering》1999,65(2):176-181
Thermal resistance of Saccharomyces cerevisiae was found to be drastically dependent on the kinetics of heat perturbation. Yeasts were found to be more resistant to a plateau of 1 h at 50 degrees C after a slope of temperature increase (slow and linear temperature increments) than after a shock (sudden temperature change). Thermotolerance was mainly acquired between 40-50 degrees C during a heat slope, i.e., above the maximal temperature of growth. The death of the yeasts subjected to a heat shock might be related to the loss of membrane integrity: intracellular contents extrusion, i.e., membrane permeabilization, was found to precede cell death. However, the permeabilization did not precede cell death during a heat slope and, therefore, membrane permeabilization was a consequence rather than a cause of cell death. During a slow temperature increase, yeasts which remain viable may have time to adapt their plasma membrane and thus maintain membrane integrity. 相似文献
107.
108.
109.
110.
Serotonergic status in human blood 总被引:5,自引:0,他引:5